(2-acetamido-1,3-thiazol-4-yl)methyl 2-[(5S,9R)-7,7,9-trimethyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetate

C19H26N4O5S — CID 92784237

IUPAC(2-acetamido-1,3-thiazol-4-yl)methyl 2-[(5S,9R)-7,7,9-trimethyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetate
SMILESCC(=O)Nc1nc(COC(=O)CN2C(=O)N[C@]3(C[C@H](C)CC(C)(C)C3)C2=O)cs1
InChIInChI=1S/C19H26N4O5S/c1-11-5-18(3,4)10-19(6-11)15(26)23(17(27)22-19)7-14(25)28-8-13-9-29-16(21-13)20-12(2)24/h9,11H,5-8,10H2,1-4H3,(H,22,27)(H,20,21,24)/t11-,19+/m1/s1
InChIKeyFLLQHGVIPPDPFT-WYRIXSBYSA-N
MW422.51 g/mol
LogP2.28
Rot. Bonds5

About (2-acetamido-1,3-thiazol-4-yl)methyl 2-[(5S,9R)-7,7,9-trimethyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetate

(2-acetamido-1,3-thiazol-4-yl)methyl 2-[(5S,9R)-7,7,9-trimethyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetate (PubChem CID 92784237) has the molecular formula C19H26N4O5S and a molecular weight of 422.51 g/mol. Its IUPAC name is (2-acetamido-1,3-thiazol-4-yl)methyl 2-[(5S,9R)-7,7,9-trimethyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetate.

Molecular Properties

Compound Name(2-acetamido-1,3-thiazol-4-yl)methyl 2-[(5S,9R)-7,7,9-trimethyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetate
PubChem CID92784237
Molecular FormulaC19H26N4O5S
Molecular Weight422.51 g/mol
Exact Mass422.16
IUPAC Name(2-acetamido-1,3-thiazol-4-yl)methyl 2-[(5S,9R)-7,7,9-trimethyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetate
SMILESCC(=O)Nc1nc(COC(=O)CN2C(=O)N[C@]3(C[C@H](C)CC(C)(C)C3)C2=O)cs1
InChIInChI=1S/C19H26N4O5S/c1-11-5-18(3,4)10-19(6-11)15(26)23(17(27)22-19)7-14(25)28-8-13-9-29-16(21-13)20-12(2)24/h9,11H,5-8,10H2,1-4H3,(H,22,27)(H,20,21,24)/t11-,19+/m1/s1
InChIKeyFLLQHGVIPPDPFT-WYRIXSBYSA-N
XLogP2.28
TPSA117.70 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500422.51
LogP ≤ 52.28
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze (2-acetamido-1,3-thiazol-4-yl)methyl 2-[(5S,9R)-7,7,9-trimethyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2-acetamido-1,3-thiazol-4-yl)methyl 2-[(5S,9R)-7,7,9-trimethyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetate?
The IUPAC name of (2-acetamido-1,3-thiazol-4-yl)methyl 2-[(5S,9R)-7,7,9-trimethyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetate (CID 92784237) is (2-acetamido-1,3-thiazol-4-yl)methyl 2-[(5S,9R)-7,7,9-trimethyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetate.
What is the SMILES notation for (2-acetamido-1,3-thiazol-4-yl)methyl 2-[(5S,9R)-7,7,9-trimethyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetate?
The canonical SMILES for (2-acetamido-1,3-thiazol-4-yl)methyl 2-[(5S,9R)-7,7,9-trimethyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetate is CC(=O)Nc1nc(COC(=O)CN2C(=O)N[C@]3(C[C@H](C)CC(C)(C)C3)C2=O)cs1.
What is the InChIKey of (2-acetamido-1,3-thiazol-4-yl)methyl 2-[(5S,9R)-7,7,9-trimethyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetate?
The InChIKey is FLLQHGVIPPDPFT-WYRIXSBYSA-N. The full InChI is InChI=1S/C19H26N4O5S/c1-11-5-18(3,4)10-19(6-11)15(26)23(17(27)22-19)7-14(25)28-8-13-9-29-16(21-13)20-12(2)24/h9,11H,5-8,10H2,1-4H3,(H,22,27)(H,20,21,24)/t11-,19+/m1/s1.
What are the key properties of (2-acetamido-1,3-thiazol-4-yl)methyl 2-[(5S,9R)-7,7,9-trimethyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetate?
(2-acetamido-1,3-thiazol-4-yl)methyl 2-[(5S,9R)-7,7,9-trimethyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetate has a molecular weight of 422.51 g/mol, XLogP of 2.28, 5 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (2-acetamido-1,3-thiazol-4-yl)methyl 2-[(5S,9R)-7,7,9-trimethyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl]acetate is sourced from PubChem (CID 92784237), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).